Claudin-1 expression is induced by tumor necrosis factor-α in human pancreatic cancer cells

International Journal of Molecular Medicine

Volumn 22, Issue 5, 2008, Pages 645-649

  Kondo, Jun ^a,b   Sato, Fuyuki ^a   Kusumi, Tomomi ^a   Liu, Yang ^a   Motonari, Ohashi ^a   Sato, Tatsusuke ^b   Kijima, Hiroshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Claudin 1; PANC 1; Poly (ADP ribose) polymerase; Tumor necrosis factor

Indexed keywords

CLAUDIN 1; COL11A2 PROTEIN, HUMAN; COLLAGEN TYPE 11; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METASTASIS; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN TYPE XI; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59149095708     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm-00000067     Document Type: Article

References (28)

1. Tsukita S, Furuse M and Itoh M: Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol 11: 628-633, 1999.
2. Tsukita S, Furuse M and Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293, 2001.
3. Furuse M, Fujita K, Hiiragi T, Fujimoto K and Tsukita S: Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141: 1539-1550, 1998.
4. Tsukita S and Furuse M: Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 9: 268-273, 1999.
5. Ivanov AI, Nusrat A and Parkos CA: Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell 15: 176-188, 2004.
6. Morohashi S, Kusumi T, Sato F, Odagiri H, Chiba H, Yoshihara S, Hakamada K, Sasaki M and Kijima H: Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int J Mol Med 20: 139-143, 2007.
7. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP and Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22: 2021-2033, 2003.
8. Krämer F, White K, Kubbies M, Swisshelm K and Weber BH: Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 107: 249-256, 2000.
9. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y and Furukawa Y: Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 12: 469-476, 2001.
10. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ and Morin PJ: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60: 6281-6287, 2000.
11. Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, Kojima T and Chiba H: Tight junctions and human diseases. Med Electron Microsc 36: 147-156, 2003.
12. Hirohashi S and Kanai Y: Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581, 2003.
13. Fazal S and Saif MW: Supportive and palliative care of pancreatic cancer. JOP 8: 240-253, 2007.
14. Korc M: Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 7: 25-41, 1998.
15. Lideståhl A, Permert J, Linder S, Bylund H, Edsborg N and Lind P: Efficacy of systemic therapy in advanced pancreatic carcinoma. Acta Oncol 45: 136-143, 2006.
16. Welsch T, Kleeff J and Friess H: Molecular pathogenesis of pancreatic cancer: advances and challenges. Curr Mol Med 7: 504-521, 2007.
17. Yeh JJ and Der CJ: Targeting signal transduction in pancreatic cancer treatment. Expert Opin Ther Targets 11: 673-694, 2007.
18. Kijima H, Yamazaki H, Nakamura M, Scanlon KJ, Osamura RY and Ueyama Y: Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer. Int J Oncol 24: 559-564, 2004.
19. Tsuchida T, Kijima H, Hori S, Oshika Y, Tokunaga T, Kawai K, Yamazaki H, Ueyama Y, Scanlon KJ, Tamaoki N and Nakamura M: Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma. Cancer Gene Ther 7: 373-383, 2000.
20. Sato T, Yamauchi N, Sasaki H, Takahashi M, Okamoto T, Sakamaki S, Watanabe N and Niitsu Y: An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration. Cancer Res 58: 1677-1683, 1998.
21. Stephens LA, Thomas HE, Ming L, Grell M, Darwiche R, Volodin L and Kay TW: Tumor necrosis factor-!-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells. Endocrinology 140: 3219-3227, 1999.
22. Kuninaka S, Yano T, Yokoyama H, Fukuyama Y, Terazaki Y, Uehara T, Kanematsu T, Asoh H and Ichinose Y: Direct influences of pro-inflammatory cytokines (IL-1β, TNF-Α and IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Cytokine 12: 8-11, 2000.
23. Baker SJ and Reddy EP: Modulation of life and death by the TNF receptor superfamily. Oncogene 17: 3261-3270, 1998.
24. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA and Lemasters JJ: The mitochondrial permeability transition is required for tumor necrosis factor α-mediated apoptosis and cytochrome c release. Mol Cell Biol 18: 6353-6364, 1998
25. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85, 1999.
26. Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM and Glembotski CC: p38 MAPK and NFkappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 275: 23814-23824, 2000.
27. Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, Norgaard P and Moses HL: Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of cmyc, cyclin D1, cyclin A and proliferating cell nuclear antigen. J Biol Chem 275: 38261-38267, 2000.
28. Maeno K, Masuda A, Yanagisawa K, Konishi H, Osada H, Saito T, Ueda R and Takahashi T: Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers. Oncogene 25: 271-277, 2006.